CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-A1811 and Pyrotinib Combo Study

CompanyDeals

Shanghai Xinhengrui Medical Technology Secures Series A Funding for Heart Failure Device Development

CompanyDeals

Beyond Therapeutics Secures Tens of Millions in Pre-Series A Financing for Ophthalmology and Oncology Pipeline

CompanyDrug

Mabwell Bioscience Receives NMPA Approval to Launch 9MW2921 Clinical Study

CompanyDeals

Centre Medical Secures Tens of Millions in Series A Financing to Expand Globally

CompanyDrug

TransThera Sciences’ TT-00420 Receives Breakthrough Designation for Cholangiocarcinoma Treatment

CompanyDrug

Shenzhen Salubris Pharmaceuticals’ SAL0120 for IgA Nephropathy Accepted for NMPA Review

Policy / Regulatory

NHSA Unveils 2023 Flying Inspection Plan for Medical Insurance Fund Oversigh

CompanyDrug

Betta Pharmaceuticals’ MCLA-129 Combo Therapy for NSCLC Gets NMPA Clinical Approval

CompanyDrug

Pfizer Launches Phase III Trial for Quadrivalent Influenza modRNA Vaccine in Argentina

CompanyDrug

Zai Lab Initiates Phase III Trial for Bemarituzumab in First-Line Gastric Cancer Treatment

CompanyDrug

Chile Expands Financial Coverage for AbbVie’s RSV Prophylaxis Synagis